Jacobio Pharma repurchases 179,400 shares, treasury stock rises to 7.33 million

Bulletin Express05-19

Jacobio Pharmaceuticals Group Co., Ltd. (Jacobio Pharma) disclosed that on 19 May 2026 it repurchased 179,400 ordinary shares on the Hong Kong Stock Exchange at prices between HKD 5.32 and HKD 5.38, for a total consideration of HKD 0.96 million (volume-weighted average price: HKD 5.37).

The buyback reduced outstanding shares (excluding treasury) by 0.02 % to 784.43 million, while treasury shares increased to 7.33 million. Total issued shares remained unchanged at 791.76 million.

Since the current mandate was approved on 10 June 2025, Jacobio Pharma has repurchased 4.31 million shares, representing 0.55 % of the share capital on the mandate date. The mandate authorises the company to repurchase up to 78.87 million shares.

Under Hong Kong Listing Rule 10.06(3)(a), the company is subject to a moratorium on issuing new shares or disposing of treasury shares until 18 June 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1113057734?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-19 17:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113057734","market":"us","top_or_hot":-1,"title":"Jacobio Pharma repurchases 179,400 shares, treasury stock rises to 7.33 million","media":"Bulletin Express","content":"<p>Jacobio Pharmaceuticals Group Co., Ltd. (Jacobio Pharma) disclosed that on 19 May 2026 it repurchased 179,400 ordinary shares on the Hong Kong Stock Exchange at prices between HKD 5.32 and HKD 5.38, for a total consideration of HKD 0.96 million (volume-weighted average price: HKD 5.37).</p>\n<p>The buyback reduced outstanding shares (excluding treasury) by 0.02 % to 784.43 million, while treasury shares increased to 7.33 million. Total issued shares remained unchanged at 791.76 million.</p>\n<p>Since the current mandate was approved on 10 June 2025, Jacobio Pharma has repurchased 4.31 million shares, representing 0.55 % of the share capital on the mandate date. The mandate authorises the company to repurchase up to 78.87 million shares.</p>\n<p>Under Hong Kong Listing Rule 10.06(3)(a), the company is subject to a moratorium on issuing new shares or disposing of treasury shares until 18 June 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jacobio Pharma repurchases 179,400 shares, treasury stock rises to 7.33 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJacobio Pharma repurchases 179,400 shares, treasury stock rises to 7.33 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-19 17:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jacobio Pharmaceuticals Group Co., Ltd. (Jacobio Pharma) disclosed that on 19 May 2026 it repurchased 179,400 ordinary shares on the Hong Kong Stock Exchange at prices between HKD 5.32 and HKD 5.38, for a total consideration of HKD 0.96 million (volume-weighted average price: HKD 5.37).</p>\n<p>The buyback reduced outstanding shares (excluding treasury) by 0.02 % to 784.43 million, while treasury shares increased to 7.33 million. Total issued shares remained unchanged at 791.76 million.</p>\n<p>Since the current mandate was approved on 10 June 2025, Jacobio Pharma has repurchased 4.31 million shares, representing 0.55 % of the share capital on the mandate date. The mandate authorises the company to repurchase up to 78.87 million shares.</p>\n<p>Under Hong Kong Listing Rule 10.06(3)(a), the company is subject to a moratorium on issuing new shares or disposing of treasury shares until 18 June 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01167","symbol_name":"加科思-B","start_time":0,"source_url":"","article_id":"1113057734","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113057734","pubTimestamp":1779183810,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jacobio Pharmaceuticals Group Co., Ltd. (Jacobio Pharma) disclosed that on 19 May 2026 it repurchased 179,400 ordinary shares on the Hong Kong Stock Exchange at prices between HKD 5.32 and HKD 5.38,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01167":"加科思-B"},"translate_title":"Jacobio Pharma回购17.94万股库存股升至733万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01167":1},"content_text":"Jacobio Pharmaceuticals Group Co., Ltd. (Jacobio Pharma) disclosed that on 19 May 2026 it repurchased 179,400 ordinary shares on the Hong Kong Stock Exchange at prices between HKD 5.32 and HKD 5.38, for a total consideration of HKD 0.96 million (volume-weighted average price: HKD 5.37).\nThe buyback reduced outstanding shares (excluding treasury) by 0.02 % to 784.43 million, while treasury shares increased to 7.33 million. Total issued shares remained unchanged at 791.76 million.\nSince the current mandate was approved on 10 June 2025, Jacobio Pharma has repurchased 4.31 million shares, representing 0.55 % of the share capital on the mandate date. The mandate authorises the company to repurchase up to 78.87 million shares.\nUnder Hong Kong Listing Rule 10.06(3)(a), the company is subject to a moratorium on issuing new shares or disposing of treasury shares until 18 June 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1113057734","isCrawlerRequest":true}